Category: Policy

4sight Friday | Chatbot Lockjaw | Dems Healthcare | Bailing Out or Propping Up?

Read 07/31/2020 Edition here. Curated by David Burda, 4sight Health’s news editor and columnist. Columns here. Find 4sight Health… Read More

By David Burda July 31, 2020

COVID-19

Podcast: 4sight Friday Podcast: 4sight Friday Roundup, Is There a Better Way to Bailout Providers?, 07/31/2020

Is There a Better Way to Bailout Providers? Listen to this week’s 4sight Friday Roundup podcast for our… Read More

By David Burda July 31, 2020

COVID-19

Make No Big Plans: The Democratic Party’s Unity Platform for Healthcare

Key Takeaways The Democratic Party’s emerging healthcare platform, crafted by a unity task force picked by former Vice… Read More

By Alina-Bonn July 28, 2020

COVID-19

Pandemic Preparedness: Beyond Bioterrorism & Federalism

One week to the day following the 911 attacks, five letters containing anthrax spores were sent the offices… Read More

By Kerry Weems July 21, 2020

COVID-19

Pandemics Cubed: Social Injustice and Chronic Disease Amplify COVID-19’s Virulence

America’s current response to COVID-19 ranges from “no worries” to struggling episodically to acutely overwhelmed. The uneven response… Read More

By Allen Weiss July 16, 2020

COVID-19

Don’t bail out. Bail in to value-based care.

Key Takeaways: Hopes for a V-shaped recovery in healthcare spending are fading fast as COVID-19 caseloads, hospitalizations and… Read More

By David W. Johnson July 9, 2020

COVID-19

4sight Friday | The Folly of Furloughs | COVID-19 and the Economy | Contact Trace or Die

Read 07/03/2020 Edition here. Curated by David Burda, 4sight Health’s news editor and columnist. Columns here. Find 4sight Health… Read More

By David Burda July 3, 2020

COVID-19

Countering the Negative Consequences of COVID-Induced Healthcare Consolidation

The COVID-19 outbreak in the U.S. is leaving a lot of financially struggling hospitals and medical practices in… Read More

By David Burda June 18, 2020

Innovation

Testing Snafus – Testing, Testing, 1, 2, Whoa!

Key Takeaways: Increasing scrutiny of laboratory-developed tests (LDTs) for COVID-19 casts doubts on accuracy. Critics fear many FDA-approved… Read More

By Merrill Goozner June 11, 2020

Policy

Filter Insights By:

Search Insights